Home › Funds › CINCINNATI FINANCIAL CORP › ABT

CINCINNATI FINANCIAL CORP position in ABT

ABBOTT LABORATORIES · Health Care

CINCINNATI FINANCIAL CORP reported holding 237,800 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$23.5M, representing 0.44% of its reported portfolio and ranking #40 among its reported holdings. CINCINNATI FINANCIAL CORP has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)237.80K sh
Reported value held$23.50M
Portfolio Weight0.44%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CINCINNATI FINANCIAL CORP's ABT position evolved

CINCINNATI FINANCIAL CORP first disclosed a stake in ABT in Q3 2023 at 237,800 shares (US$23.0M). The position peaked in Q2 2025 at 237,800 shares, worth US$32.3M. Across 13 filings, CINCINNATI FINANCIAL CORP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 237,800 shares valued at US$23.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 237.80K $23.03M New
Q4 2023 237.80K $26.17M Hold
Q1 2024 237.80K $27.03M Hold
Q2 2024 237.80K $24.71M Hold
Q3 2024 237.80K $27.11M Hold
Q4 2024 237.80K $26.90M Hold
Q1 2025 237.80K $31.54M Hold
Q2 2025 237.80K $32.34M Hold
Q3 2025 237.80K $31.85M Hold
Q4 2025 237.80K $29.79M Hold
Q1 2026 237.80K $24.41M Hold
Q2 2026 237.80K $21.58M Hold
Q3 2026 237.80K $23.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has CINCINNATI FINANCIAL CORP held ABT?

CINCINNATI FINANCIAL CORP has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CINCINNATI FINANCIAL CORP's current position in ABT?

As of Q3 2026, CINCINNATI FINANCIAL CORP holds 237.80K shares of ABT (ABBOTT LABORATORIES), valued at $23.50M, representing 0.44% of its reported portfolio and ranking #40.

Has CINCINNATI FINANCIAL CORP been buying or selling ABT?

In the latest 13F filing (Q3 2026), CINCINNATI FINANCIAL CORP held unchanged its position in ABT. The position peaked in Q2 2025 at 237.80K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.